Presentation TCTAP 2013 Can We Afford TAVR? Economic Insights from the PARTNER Trial Presenter: David J. Cohen April 25, 2013
Presentation TCTAP 2013 In-hospital outcome of interventional treatment in elderly patients with acute coronary syndromes Presenter: W. Wojakowski April 25, 2013
Presentation TCTAP 2013 The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax Presenter: Seung-Jung Park April 24, 2013
Presentation TCTAP 2013 Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive Presenter: Adnan Kastrati April 24, 2013
Presentation TCTAP 2013 The Gold Standard for PCI Will Be Bioabsorbable DES Presenter: Ron Waksman April 24, 2013
Presentation TCTAP 2013 Surgical AVR Remains the Procedure of Choice for Most AS Patients Presenter: David P. Taggart April 24, 2013
Presentation TCTAP 2013 The Future Is: New Antiplatelet Agents, Selective Platelet Function Testing, and Patient-Specific DAPT Duration Presenter: Matthew J. Price April 24, 2013
Presentation TCTAP 2013 Controversies: TAVI is Preferred in All High-Risk Patients Presenter: Alain Cribier April 24, 2013
Presentation TCTAP 2013 Resisting the Bioabsorble Stent Bandwagon: A Healthy Dose of Skepticism Presenter: David J. Cohen April 24, 2013